PREVAIL Begins Clinical Research on Lassa Fever Study Vaccine
MONROVIA – The Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), a joint Liberia-United States research partnership, has launched…
MONROVIA – The Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), a joint Liberia-United States research partnership, has launched…
MONROVIA – Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) has admonished Liberians and people around the world to…
Monrovia – The Partnership for Research on Ebola Virus in Liberia (PREVAIL) recently conducted a clinical research study where Ebola survivors and…
Monrovia – The Partnership for Research on Ebola Virus in Liberia (PREVAIL) has received high marks for its ongoing research program in…
Monrovia – Emmanuel Lansana, the first vaccine volunteer, said his inoculation with the Ebola Vaccine on February 2, 2015 was met with…
Monrovia – The Partnership for Research on Ebola Virus in Liberia (PREVAIL) announced the start of a new study to investigate if…
Monrovia – The Principal Investigator of Partnership for Research on Ebola Virus in Liberia (PREVAIL) Dr. Mosoka Fallah says Protecting the population…
Monrovia – Liberian health reporters have expressed delight over the regular media training and information exchange forum organized by the Partnership for…
Monrovia – The Social Mobilization and Communications Team at the Liberia-US Clinical Research Partnership, PREVAIL climaxed its month-long activities with the hosting…
Monrovia – The ongoing community engagements and outreach activities in support of the Ebola Natural History Study continues to reach out to…